Bulletins

5 October

2020

Bulletins

Trade Marks and design rights after Brexit

This bulletin covers some important changes to trade mark and design rights in the UK that will take place on 1 January 2021. Background The United Kingdom (UK) left the European Union (EU) on 31 January 2020 and is currently in a Brexit Transition Period that ends on 31 December 2020. Therefore, from 1 January... right arrow

30 September

2020

Bulletins

High Court confirms that an Artificial Intelligence cannot be named as an inventor

Last year, the UK Intellectual Property Office (UKIPO) rejected two UK patent applications (GB1816909.4 and GB1818161.0) on the grounds of an invalid designation of inventor. The applications had been filed by Dr Stephen Thaler, who named his creation (the AI “DABUS”) as the inventor. The UKIPO’s decision was based on the conclusion that, under the... right arrow

15 September

2020

Bulletins

T0161/18 – Sufficiency and Machine Learning at the EPO

In recent years, the European Patent Office (EPO) has made it eminently clear that European patents may be granted for machine learning inventions. Given the way in which such inventions are trained based on a training dataset, it can often be difficult to know exactly what algorithm the system will perform once trained up. This... right arrow

28 August

2020

Bulletins

Renewal fee increases in Australia

The Australian Patent Office will be changing various official fees for patents, trademarks and designs from 1 October 2020. Notably, patent renewal fees for the 12th – 19th anniversaries are increasing substantially. There are also significant increases for patent renewal fees for the 20th – 24th anniversaries, which apply to pharmaceutical patents having an extended... right arrow

11 August

2020

Bulletins

Neurim Overturned – CJEU severely restricts availability of second medical use SPCs

The Court of Justice of the European Union (CJEU) has ruled in Santen (C‑673/18) that a Supplementary Protection Certificate (SPC) cannot be granted for a new medical use of a previously approved active ingredient, because an SPC must be based on the first marketing authorisation (MA) to place a product on the market as a... right arrow

1 2 3 10

Newsletter

boult.bites TM Summer 2020

Welcome to the new look boult.bites TM. In this issue you will find the latest insights team news, and highlight news from the industry, including future webinars dates and a profile article on trade mark Partner, Rachel Conroy.

boult.bites TM Spring 2020

In this edition we introduce you to our expanded team in Germany; update you on upcoming Boult Wade Tennant events; and highlight key news and updates from the industry, including an update on Brexit.

boult.bites TM Autumn 2019

In this issue, we update you on important developments in the industry; a reversed Board of Appeal decision by the General Court; an important case for brand owners; and general updates TM team and firm updates.

View all

Blog

Be Brexit-ready with our Brexit toolkit